BioLife Solutions, Inc.

BioLife Solutions, Inc. BioLife Solutions is a leading supplier of class-defining cell and gene therapy bioproduction tools and services.

Preserving the Promise™

It is our mission to protect the integrity of cells and provide trusted tools, services, and expertise that can enable our customers to advance the development and delivery of cell and gene therapies. Our tools portfolio includes our proprietary CryoStor® and HypoThermosol® biopreservation media for shipping and storage, the ThawSTAR® family of automated, water-free thawing products, evo® cold chain management system, Custom Biogenic Systems high capacity storage freezers, Stirling Ultracold mechanical freezers, SciSafe biologic storage services, and Sexton Biotechnologies cell processing tools. For more information, please visit www.biolifesolutions.com, www.scisafe.com, www.stirlingultracold.com, or www.sextonbio.com and follow BioLife on Twitter.

12/19/2025

BioLife incorporates ice recrystallization inhibitors (IRIs) into cryopreservation workflows and reduces recrystallization-driven injury and variability.

🌟 Friendly Reminder 🌟BioLife Solutions offices are closed from Monday, December 22, 2025, through Friday, January 2, 202...
12/18/2025

🌟 Friendly Reminder 🌟

BioLife Solutions offices are closed from Monday, December 22, 2025, through Friday, January 2, 2026.

We’ve had an amazing year, and we want to show our gratitude and appreciation to our team members, vendors, and customers by taking a well-deserved holiday break.

Operations and shipping of products will resume on Monday, January 5. We will come back refreshed and ready to assist you in 2026.

Happy Holidays to all! 🎁

Our October 9 webinar, “Closing the loop: eliminating open handling risks in CGT manufacturing,” with Cell & Gene Therap...
12/18/2025

Our October 9 webinar, “Closing the loop: eliminating open handling risks in CGT manufacturing,” with Cell & Gene Therapy Insights is available now as an article.

🔗 Erik Woods of Health, Jon Pileggi of CTMC, and Sean Werner of BioLife Solutions, outline how transitioning from open, manual manufacturing to fully closed-system processing and closed cryogenic storage significantly improves the scalability, cost efficiency, and sterility of cell and gene therapy production.

🔗 Closed, single-use technologies are essential infrastructure for compliant and economically viable CGT manufacturing at commercial scale.

Review the data, comparative models, and the results from a CAR-T case study. 📊

https://www.insights.bio/cell-and-gene-therapy-insights/journal/article/3701/closedsystem-process-optimization-for-cgt-manufacturing-and-storage

AABB recently released the 4th Edition of Apheresis: Principles and Practice, Volume 3: Cellular Therapy Apheresis. ❄️ C...
12/17/2025

AABB recently released the 4th Edition of Apheresis: Principles and Practice, Volume 3: Cellular Therapy Apheresis.

❄️ Chapter 7, “The Cryopreservation of Apheresis Products in Cell Therapy,” features contributions from Dr. Jason Acker and colleagues at the University of Alberta.

❄️ This chapter provides a comprehensive overview of the science, current practices, limitations, and emerging innovations related to the cryopreservation of apheresis-derived blood products used in transfusion medicine and cell therapy manufacturing.

❄️ Dr. Acker and team emphasize that although cryopreservation is mature as a scientific discipline, its translation into clinical practice is inconsistent, and significant optimization opportunities remain—particularly for stem cell and adoptive cell therapies (CAR-T, TIL, etc.) where cryopreservation is operationally essential.

Check out an overview of Volume 3 and make sure to order your print copy today! 📖

https://www.aabb.org/aabb-store/product/apheresis-principles-and-practice-4th-ed-volume-3-cellular-therapy-apheresis-print-19510136

About a month ago, we released The Cell Summit ’25 Proceedings eBook with Genetic Engineering & Biotechnology News (GEN)...
12/12/2025

About a month ago, we released The Cell Summit ’25 Proceedings eBook with Genetic Engineering & Biotechnology News (GEN).

💡 If you missed it, this eBook provides actionable takeaways from speakers at The Cell Summit ’25 event that we hosted in Indianapolis from August 5-6, 2025. The Cell Summit focused on cell and gene therapy manufacturing solutions, best practices, process optimizations, and innovative technologies.

💡 The eBook features contributions from our co-sponsors Azenta Life Sciences, Entegris, and part of our scientific bench - Alireza Abazari, Sean Werner, Jason Acker, and Robert Ben.

We’re already planning for The Cell Summit ’26!

💻 Download the eBook for CGT insights: https://promo.genengnews.com/biolife-cell-summit-25-proceedings/

Cell and gene therapies (CGTs) are advancing rapidly, but their success hinges on maintaining the integrity of living ce...
12/09/2025

Cell and gene therapies (CGTs) are advancing rapidly, but their success hinges on maintaining the integrity of living cells throughout manufacturing, storage, distribution, and at the patient point-of-care.

� An often-overlooked threat is transient warming events (TWEs). These are brief temperature excursions that can silently damage cryopreserved cells. Even short-lived warming events can trigger biological stress leading to delayed onset cell death and loss of therapeutic potency.

� In a recent article with HIT Consultant Media, Dr. Jason Acker of Panthera CryoSolutions, part of BioLife Solutions, states that when CGTs scale commercially and move across multiple sites, TWEs become a critical operational and patient-safety risk.

How do we reduce the risk of TWEs�
Dr. Acker advises on proactive measures that can be taken to ensure consistent, safe, and commercially viable delivery of high-value therapies.

� Read on for solutions to TWE challenges: https://hitconsultant.net/2025/12/02/transient-warming-events-twes-the-silent-threat-to-cell-and-gene-therapy-integrity/

To celebrate their 10th anniversary and 10 strong years of new advanced therapy developments, Cell & Gene Therapy Insigh...
12/04/2025

To celebrate their 10th anniversary and 10 strong years of new advanced therapy developments, Cell & Gene Therapy Insights created an infographic highlighting some of the major CGT breakthroughs and milestones.

We’re proud to support these brilliant organizations, with BioLife’s biopreservation media and cryogenic storage vials being utilized in almost half of the therapies shared in this infographic.

We’ve seen the industry transform from basic research to preliminary trials to final regulatory body approvals, globally.

As winter holidays approach, we invite you to celebrate these achievements for patients with us!

Download the infographic: https://www.insights.bio/cell-and-gene-therapy-insights/journal/article/3613/a-decade-of-breakthroughs-10-years-of-cell-gene-therapy

🚨 IMPORANT NOTICE 🚨BioLife Solutions will be closed from Monday, December 22, 2025, through Friday, January 2, 2026. We ...
12/03/2025

🚨 IMPORANT NOTICE 🚨

BioLife Solutions will be closed from Monday, December 22, 2025, through Friday, January 2, 2026. We will resume normal business operations and shipping of product on Monday, January 5, 2026.

If you anticipate needing materials during this period, we encourage you to place your order soon to ensure timely fulfillment.

For support or to place an order, please email: SalesOne@biolifesolutions.com or call: 1-866-424-6543.

The BioLife team thanks you for an amazing year. We can’t wait to come back refreshed and ready to assist with your biopreservation and cell processing needs in 2026! 🎇

12/02/2025

About one and a half months ago, we launched a brand and website refresh to simplify, standardize, and strengthen our connections within the cell and gene therapy (CGT) industry.

This refresh focuses most on improving clarity, trust, and collaboration, so developers and manufacturers like you can move faster, reduce risk, and deliver unique therapies to patients with greater confidence.

Our latest blog post discusses the details of this refresh and how it serves YOU with:

* Easier website navigation
* Validated data, visuals, and links to supporting evidence
* Biopreservation best practices
* Optimization and standardization of cell processing workflows
* Scientific expertise and regulatory support

Let’s ‘preserve the promise’ together - https://www.biolifesolutions.com/resource-center/insights-blog/preserving-the-promise/

BioLife has a lot to be thankful for this year…We are beyond grateful for our outstanding customers, vendors, investors,...
11/26/2025

BioLife has a lot to be thankful for this year…We are beyond grateful for our outstanding customers, vendors, investors, and of course, our team members.

BioLife’s U.S.-based offices will be closed on Thursday, November 27, and Friday, November 28, to observe the Thanksgiving holiday. Normal business hours will resume on Monday, December 1.

If you have any questions or concerns, please contact us here: https://www.biolifesolutions.com/contact/general-inquiries/

Have a festive, fun, and safe Thanksgiving holiday weekend!

In less than one week, Informa Connect Life Sciences' “Cell & Gene Therapy International Europe 2025” conference kicks o...
11/25/2025

In less than one week, Informa Connect Life Sciences' “Cell & Gene Therapy International Europe 2025” conference kicks off in Berlin, Germany.

Come by booth 7 to meet Steven Thompson, Andreas Giger, and Jordi Martí Gascón. If you’re an old friend, we enjoy your company too!

Steven will be presenting during the “Live Labs Tour” in the exhibit hall on December 1, 1:05-1:20pm GMT. Join us at our booth to discuss the impact of cell culture ancillary materials on cell health and performance.

Can’t make it then? Stop by later and ask us about closed-system and automation solutions, bioprocessing optimization, scale-up strategies, and biopreservation best practices.

Add ‘BioLife Solutions’ to your schedule in the ConnectMe app: https://informaconnect.com/celltherapy/connectme/

BioProcess International shared our exciting news about The Aby J. Mathew Center for Biopreservation Excellence (“The Ce...
11/21/2025

BioProcess International shared our exciting news about The Aby J. Mathew Center for Biopreservation Excellence (“The Center”) soft launch and interviewed Dr. Alireza Abazari, Director and Leader of The Center.

The Center aims to close the expertise gap in biopreservation for cell and gene therapy and biopharma manufacturers. It will serve as a hub for collaboration, research, training, and consulting - helping developers optimize cell potency and reliability during therapy development and delivery.

> Check out the article: https://www.bioprocessintl.com/facilities-capacity/biolife-opens-biopreservation-center-in-washington-to-support-cgt-manufacturing

> Join The Center’s waiting list: https://go.biolifesolutions.com/The-Center

Address

3303 Monte Villa Pkwy, Suite 310
Bothell, WA
98021

Opening Hours

Monday 9am - 5pm
Tuesday 9am - 5pm
Wednesday 9am - 5pm
Thursday 9am - 5pm
Friday 9am - 5pm

Alerts

Be the first to know and let us send you an email when BioLife Solutions, Inc. posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram